Unique ID issued by UMIN | UMIN000045148 |
---|---|
Receipt number | R000051516 |
Scientific Title | Study on the safety of thiopurine preparations during pregnancy |
Date of disclosure of the study information | 2021/10/03 |
Last modified on | 2022/08/13 12:45:44 |
Study on the safety of thiopurine preparations during pregnancy
preMENDEL2
Study on the safety of thiopurine preparations during pregnancy
preMENDEL2
Japan |
All diseases for which thiopurine preparations are used
Medicine in general | Gastroenterology | Hepato-biliary-pancreatic medicine |
Pneumology | Nephrology | Neurology |
Clinical immunology | Surgery in general | Obstetrics and Gynecology |
Pediatrics | Adult | Child |
Others
YES
The purpose of this study is to clarify whether there is any association between pregnancy and childbirth complications, including miscarriage and stillbirth, and child development and birth complications in patients taking thiopurine preparations, especially whether the NUDT15 gene polymorphism of the patient, male partner, and fetus is associated with these complications.
Safety,Efficacy
Frequency of NUDT15 genotype in infants for each NUDT15 genotype pair of parents
Frequency of pregnancy complications, frequency of genetic mutations in children, and analysis of transmission disequilibrium in pregnancies taking thiopurine
Observational
Not applicable |
Not applicable |
Male and Female
Patients: Women over 20 years old. Any underlying disease is acceptable. Then, patients who satisfy any one of A or B.
A) Female patients who became pregnant while taking a thiopurine preparation (thiopurine can be discontinued after pregnancy)
B) Patients who have been treated with a thiopurine preparation for more than 60 days during pregnancy
Male partner (participation required*): Male patients aged 20 years or older.
Male partner with pregnancy corresponding to either A or B above
Child (participation required* for children who are pregnant while taking thiopurine): Any age or sex
All children of patient/partner pairs participating in this study
Children who became pregnant or gave birth during the period when they were not taking thiopurine products can also participate voluntarily.
However, if the child is born in a pregnancy during which the patient was taking thiopurine, the child's participation is *required* in principle.
Cases in which the medication status at the time of pregnancy cannot be determined.
Cases in which all the specimens of the partner (required) and the child (required for children born in pregnancies while taking thiopurine, optional for other pregnancies) are not available.
400
1st name | Yoichi |
Middle name | |
Last name | Kakuta |
Tohoku University Hospital
Division of Gastroenterology
9808574
1-1 Seiryo Aoba, Sendai
0227177171
ykakuta@med.tohoku.ac.jp
1st name | Yoichi |
Middle name | |
Last name | Kakuta |
Tohoku University Hospital
Division of Gastroenterology
980-8574
1-1 Seiryo Aoba, Sendai
0227177171
https://premendel.ibd.ai/
ykakuta@med.tohoku.ac.jp
Tohoku University Hospital
Japan Agency for Medical Research and Development
Japanese Governmental office
Tohoku University Graduate School of Medicine Ethics Committee
1-1 Seiryo-machi, Aoba-ku, Sendai
022-717-3867
med-kenkyo@grp.tohoku.ac.jp
NO
2021 | Year | 10 | Month | 03 | Day |
Unpublished
Enrolling by invitation
2021 | Year | 09 | Month | 28 | Day |
2021 | Year | 09 | Month | 29 | Day |
2021 | Year | 10 | Month | 04 | Day |
2024 | Year | 03 | Month | 31 | Day |
2025 | Year | 03 | Month | 31 | Day |
None
2021 | Year | 08 | Month | 13 | Day |
2022 | Year | 08 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051516